BioNTech SE Current Liabilities
BioNTech SE (BNTX) had Current Liabilities of EUR 2.14 billion as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2026-03-10
- 2025-12-31: Current Liabilities 2.14B EUR.
- 2024-12-31: Current Liabilities 2.52B EUR.
- 2023-12-31: Current Liabilities 2.07B EUR.
- 2022-12-31: Current Liabilities 2.95B EUR.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 2.14B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 2.52B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 2.07B EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | 2.95B EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 3.48B EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 606.00M EUR 20-F/A · filed 2022-10-26 | 606.01M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 138.14M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 126.12M EUR 20-F · filed 2020-03-31 |